Sarcosine-Loaded Dendritic Cell Migration for Brain Tumor Therapy
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current immunotherapy approaches for treating brain tumors, such as dendritic cell-based vaccines, face challenges in enhancing the migration of dendritic cells to local lymph nodes, which is crucial for an effective immune response.
Innovation Solution
Intracellular loading of dendritic cells with sarcosine, either through electroporation or culturing in sarcosine-containing medium, significantly enhances their migration to local lymph nodes, achieving a synergistic effect when combined with a tetanus toxoid recall response.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Speed
If dendritic cells are used in vaccine therapy, then immune response is generated, but migration of dendritic cells to local lymph nodes is insufficient
Solution Approach 1:
The patent changes the chemical composition parameters of dendritic cells by loading them with sarcosine, a common metabolite. This parameter change (intracellular sarcosine concentration) directly enhances the migration speed and efficiency of dendritic cells to local lymph nodes, thereby resolving the contradiction between migration capability and immune response efficacy
Solution Approach 2:
Sarcosine acts as an intermediary substance that mediates the enhancement of dendritic cell migration. By introducing this metabolic intermediate into the system, the patent facilitates improved transport of dendritic cells to lymph nodes without directly altering the cells' structural or functional properties, thus enhancing migration while maintaining immune response reliability
2Reliability
If dendritic cell migration is enhanced, then treatment efficacy improves, but complexity of cell preparation increases
Solution Approach 1:
The patent employs sarcosine, a common metabolite that cells can naturally process, to enhance dendritic cell migration. This approach leverages the cell's own metabolic pathways, allowing the cells to self-enhance their migration capability without requiring complex external delivery systems or sophisticated preparation protocols, thus improving treatment efficacy while minimizing preparation complexity
Solution Approach 2:
Sarcosine is a simple, inexpensive metabolite that can be readily obtained and used for cell loading. This approach replaces complex, expensive modification techniques with a simple chemical treatment using a readily available substance, thereby enhancing treatment efficacy while keeping the preparation process simple and cost-effective
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The enhanced migration of sarcosine-loaded dendritic cells to lymph nodes improves the immune response and increases the killing of malignant brain tumor cells, potentially leading to improved treatment outcomes and increased patient survival.
Implementation Method 1
The cells were electroporated with sarcosine
Data Source
AI summary
Cell-based compositions and methods for targeting and treating human diseases, including cancers and infectious diseases, are provided, wherein exogenous intracellular sarcosine is used for improved delivery of the composition.